GlassScriptPhysician profile
Ladd Michael Nolin
NPI 1952312738
$3,226.06
in general payments reported to CMS, 2019-2025
19 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $32.52 · 2021: $112 · 2022: $532 · 2023: $1,129 · 2024: $702 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,239 · Entertainment: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,238.79 |
| Entertainment | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,044.68 | 2019-2025 | Dailies Total1, Clareon, Clareon Panoptix Pro |
| Sun Pharmaceutical Industries INC. | $350.31 | 2019-2024 | Cequa |
| Oyster Point Pharma, INC. | $316.53 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $216.76 | 2023-2024 | Vyzulta, Infuse |
| Abbvie INC. | $202.14 | 2022-2023 | |
| Dompe US, INC. | $158.27 | 2023-2024 | Oxervate |
| Mallinckrodt Hospital Products INC. | $142.01 | 2024 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.59 | 2019-2021 | |
| Amgen INC. | $124.92 | 2024 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $108.58 | 2025 | Acuvue |
| Biotissue Holdings INC. | $95.01 | 2023-2024 | |
| Apellis Pharmaceuticals, INC. | $79.26 | 2023 | Syfovre |
| Allergan, INC. | $63.60 | 2019-2021 | |
| Coopervision INC. | $53.75 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Ani Pharmaceuticals, INC. | $42.19 | 2025 | Purified Cortrophin Gel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $26.70 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $23.18 | 2021 | |
| Lkc Technologies, INC. | $18.40 | 2024 | |
| Quidel Corporation | $18.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ladd Nolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.